4
0.425
-0.05 (-10.53%)
| Previous Close | 0.475 |
| Open | 0.475 |
| Volume | 3,222,289 |
| Avg. Volume (3M) | 1,259,890 |
| Market Cap | 197,854,512 |
| Price / Sales | 70.62 |
| Price / Book | 15.26 |
| 52 Weeks Range | |
| Earnings Date | 28 Aug 2025 - 1 Sep 2025 |
| Operating Margin (TTM) | -811.75% |
| Diluted EPS (TTM) | -0.110 |
| Quarterly Revenue Growth (YOY) | 265.30% |
| Total Debt/Equity (MRQ) | 8.05% |
| Current Ratio (MRQ) | 1.03 |
| Operating Cash Flow (TTM) | -30.28 M |
| Levered Free Cash Flow (TTM) | -28.41 M |
| Return on Assets (TTM) | -23.32% |
| Return on Equity (TTM) | -52.37% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (AU) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | 4DMEDICAL FPO [4DX] | - | - |
AIStockmoo Score
-0.1
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.13 |
|
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 19.69% |
| % Held by Institutions | 0.60% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |